News Press

Asia Pacific Drug Modelling Software Market Growth, Trends, Absolute Opportunity and Value Chain 2020-2027

According to our new market research study on “Asia Pacific Drug Modelling Software Market to 2027 – Regional Analysis and Forecast – by Product Type, and Application” the market is expected to reach US$ 2,401.22 million by 2027 from US$ 1,252.66 million in 2019; it is estimated to grow at a CAGR of 8.8% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific drug modelling software market and the factors driving the market growth along with those hindering it.

In 2019, the software segment accounted for the highest share of the market. Also, the same segment is estimated to grow at the highest CAGR in the forecast period. Growth of this segment is attributed to the growing demand for effective therapeutics and increase in drug discovery efforts of various biologics across a wide range of therapeutics. In addition, strategic activities by service providers such as collaborations, product advancement, and product launch in order to expediate drug discovery timeline are further accelerating the growth of the market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00013991/

Company Profiles

  • Crown Bioscience Inc (JSR life science)
  • Genedata AG
  • Biognos AB
  • Dassault Systèmes
  • Acellera

The growth of the Asia Pacific drug modelling software market is mainly attributed to the rapid integration of AI for the drug discovery, increasing preference for personalized medicine, high R&D spending for novel therapeutic applications and presence of major market players. However, the less adoption in emerging countries is the major factor hindering the market growth in Asia Pacific.

Genedata AG; Biognos AB; Dassault Systèmes; Acellera; and Crown Bioscience Inc (JSR life science) are among the leading companies operating in the Asia Pacific drug modelling software market.

ASIA PACIFIC DRUG MODELLING SOFTWARE MARKET SEGMENTATION

By Product Type

  • Database
  • Software
  • Others

By Application

  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modeling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
  • Simulation Software
  • Cellular Simulation
  • Others

By Country

  • India
  • China
  • Japan
  • South Korea
  • Australia

Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00013991/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.